drugset / Trial / NCT00394225

Helium-Hyperoxia and 6MWT Distance in COPD

NCT00394225

RandomizedCrossoverSingle-blindTreatment

Summary

We assessed the effect of altering inspired gas on the 6MWT distance in COPD. We hypothesized that HeO2 would improve walking distance and reduce shortness of breath compared to both RA and O2, and potentially improve quality of life for COPD patients.

Timeline

Start
2005-07
Primary completion
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Helium Small molecule 70 % Other
Subject Oxygen Other / unclassified 30 % Other
Subject Oxygen Other / unclassified 100 % Other